DE69707121T2 - Neue vitamin-d-analoga - Google Patents

Neue vitamin-d-analoga

Info

Publication number
DE69707121T2
DE69707121T2 DE69707121T DE69707121T DE69707121T2 DE 69707121 T2 DE69707121 T2 DE 69707121T2 DE 69707121 T DE69707121 T DE 69707121T DE 69707121 T DE69707121 T DE 69707121T DE 69707121 T2 DE69707121 T2 DE 69707121T2
Authority
DE
Germany
Prior art keywords
pct
analoga
new vitamin
sec
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69707121T
Other languages
English (en)
Other versions
DE69707121D1 (de
Inventor
Gunnar Grue-Sorensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Application granted granted Critical
Publication of DE69707121D1 publication Critical patent/DE69707121D1/de
Publication of DE69707121T2 publication Critical patent/DE69707121T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DE69707121T 1996-04-03 1997-03-21 Neue vitamin-d-analoga Expired - Fee Related DE69707121T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9607034.7A GB9607034D0 (en) 1996-04-03 1996-04-03 Chemical compounds
PCT/DK1997/000128 WO1997037972A1 (en) 1996-04-03 1997-03-21 Novel vitamin d analogues

Publications (2)

Publication Number Publication Date
DE69707121D1 DE69707121D1 (de) 2001-11-08
DE69707121T2 true DE69707121T2 (de) 2002-07-11

Family

ID=10791549

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69707121T Expired - Fee Related DE69707121T2 (de) 1996-04-03 1997-03-21 Neue vitamin-d-analoga

Country Status (19)

Country Link
US (1) US5932565A (de)
EP (1) EP0891326B1 (de)
JP (1) JP2000508635A (de)
KR (1) KR100478741B1 (de)
CN (1) CN1075809C (de)
AT (1) ATE206394T1 (de)
AU (1) AU713630B2 (de)
CZ (1) CZ290097B6 (de)
DE (1) DE69707121T2 (de)
DK (1) DK0891326T3 (de)
ES (1) ES2163144T3 (de)
GB (1) GB9607034D0 (de)
HU (1) HUP9901600A3 (de)
NZ (1) NZ329531A (de)
PL (1) PL186771B1 (de)
PT (1) PT891326E (de)
RO (1) RO118286B1 (de)
RU (1) RU2169142C2 (de)
WO (1) WO1997037972A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1153201A (en) * 1999-10-25 2001-05-08 Strakan Limited Uses of 1,25-dihydroxy-5,6-trans vitamin D compounds and derivatives thereof
US6358939B1 (en) * 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
AU2000234564A1 (en) 2000-03-30 2001-10-15 Teijin Limited Intermediates for vitamin d and processes for the preparation thereof
EP1812011A1 (de) 2004-11-12 2007-08-01 Bioxell S.p.a. Kombinierte verwendung von vitamin-d-derivaten und antiproliferativen mitteln zur behandlung von blasenkrebs
EP2393494A1 (de) 2009-01-27 2011-12-14 Berg Biosystems, LLC Vitamin d3 und seine analoga zur linderung der nebenwirkungen einer chemotherapie
CA2770683C (en) 2009-08-14 2018-09-04 Berg Biosystems, Llc Vitamin d3 and analogs thereof for treating alopecia
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE143007T1 (de) * 1991-07-05 1996-10-15 Duphar Int Res Vitamin-d derivat, verfahren zu dessen herstellung sowie zwischenprodukte dafür
JP3493037B2 (ja) * 1991-12-18 2004-02-03 中外製薬株式会社 ２２−オキサコレカルシフェロール誘導体とその製造方法

Also Published As

Publication number Publication date
ES2163144T3 (es) 2002-01-16
PL324635A1 (en) 1998-06-08
HUP9901600A3 (en) 1999-11-29
AU713630B2 (en) 1999-12-09
RO118286B1 (ro) 2003-04-30
CN1075809C (zh) 2001-12-05
JP2000508635A (ja) 2000-07-11
EP0891326B1 (de) 2001-10-04
NZ329531A (en) 2001-03-30
PT891326E (pt) 2002-03-28
PL186771B1 (pl) 2004-02-27
KR19990035844A (ko) 1999-05-25
KR100478741B1 (ko) 2005-07-07
HUP9901600A2 (hu) 1999-09-28
US5932565A (en) 1999-08-03
CN1196720A (zh) 1998-10-21
EP0891326A1 (de) 1999-01-20
RU2169142C2 (ru) 2001-06-20
CZ898A3 (cs) 1998-06-17
CZ290097B6 (cs) 2002-05-15
WO1997037972A1 (en) 1997-10-16
GB9607034D0 (en) 1996-06-05
DE69707121D1 (de) 2001-11-08
ATE206394T1 (de) 2001-10-15
AU2567097A (en) 1997-10-29
DK0891326T3 (da) 2002-01-28

Similar Documents

Publication Publication Date Title
TR200102072T2 (tr) İltihap karşıtı maddeler olarak aromatik çok döngülü bileşimler
ATE247470T1 (de) Neue substituierte imidazolverbindungen
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
SE9502921D0 (sv) New compounds
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
DE69519577T2 (de) Prednisolonmetasulfobenzoat-zusammensetzung zur behandlung von entzündungserkrankung des darmes
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DE69707121T2 (de) Neue vitamin-d-analoga
NO20014240D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ATE345117T1 (de) Biphenylverbindungen sowie ihre anwendung als östrogene mittel
DE69310904D1 (de) Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
ATE215084T1 (de) Imidazopyridin-azolidinone
DK0841937T4 (da) Anvendelse af betaglycan til reduktion af ardannelse
YU4393A (sr) Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
MX9700113A (es) Amido-quinoxalindionas novedosas, su preparacion y uso.
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
DE59712297D1 (de) 3-alkylimidazopyridine
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
DE59305551D1 (de) Neue triazolochinazoline, ihre herstellung und verwendung
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
ES2097688A1 (es) Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LEO PHARMA A/S ZWEITNAME: LEO PHARMACEUTICAL PRODU

8339 Ceased/non-payment of the annual fee